About Us

Musculoskeletal Genomics Research Group

We integrate statistical genetics, cellular transcriptomics, and mathematical modelling to reveal the molecular and cellular mechanisms underlying musculoskeletal diseases and human skeletal biology.

Group Leader

A/Professor John P. Kemp

Google Scholar
LinkedIn

About the Group

The focus of the Musculoskeletal Genomics Research Group is to combine information from statistical and molecular genetics studies to identify high potential drug targets for treating patients with osteoporosis. The Research Group has a strong emphasis on multidisciplinary and collaborative research. Its recent studies provide evidence that mice and fish are valuable preclinical models for identifying cellular and genetic determinants of human skeletal health.

Group leader A/Prof. John Kemp is a National Health and Medical Research Council Emerging Leadership Fellow with an interest in genetic epidemiology of musculoskeletal disorders. A/Prof. Kemp’s research vision is to accelerate drug development for patients with osteoporosis. To achieve this vision, he has established the Musculoskeletal Genomics Research Group at Mater Research. Under his guidance, the group is developing innovative ways to combine information from statistical and molecular genetics studies of the skeleton to identify genes that represent drug targets for treating patients with osteoporosis. Research undertaken by the group is multidisciplinary, and benefits from established collaborations with clinical specialists, as well as with molecular and cell biologists within and outside of Mater Research.

Group Members

Dr. Yuandan Zhang

Senior Medical Officer
LinkedIn

Dr. Benjamin H. Mullin

Senior Research Officer
Google Scholar

Dr. Kaitlyn A. Flynn

Postdoctoral Research Officer
Google Scholar
LinkedIn

Mr. Nilabhra R. Das

PhD Student
Google Scholar
LinkedIn

Research Areas

Musculoskeletal Traits

Bone mineral density, trabecular bone score, bone fracture, etc.

Cardiovascular Traits

Abdominal aortic calcification, coronary artery disease, etc.

GWAS

Genome-wide association studies, meta-analysis, fine-mapping, etc.

Genetic Epidemiology

Mendelian Randomisation, genetic correlations, gene-set analysis, etc.

Single-cell Transcriptomics

Cell atlases of human bone, murine bone, and zebrafish scales, gene programmes identification, etc.

Pathway Modelling

Gene network modelling, cellular and functional annotation of networks, etc.

Latest Outputs

View all

Partners

Funders